Cetirizine Hydrochloride (cetirizine hydrochloride tablets) NDC 71205-709

Product information

Brand name (proprietary)

Cetirizine Hydrochloride

Generic name (nonproprietary)

cetirizine hydrochloride tablets

Active ingredients

Cetirizine hydrochloride — 10 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Proficient Rx LP

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 078343

Marketing start

Dec 17, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Histamine H1 Receptor Antagonists (Mechanism)

Identifiers

Product ID 71205-709_bb392ca5-d39d-4265-95b2-bc44e133101bSPL ID bb392ca5-d39d-4265-95b2-bc44e133101bSPL set ID 55b1738c-fa72-4cd1-a8e8-be41b12b593dRxCUI 1014678UNII 64O047KTOAUPC 0371205709068

Pharmacologic class

Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205070900 followed by a unit qualifier and the quantity Copy

Package 71205-0709-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 078343

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.